Can-Fite BioPharma (CANF) Cash & Current Investments (2013 - 2026)
Can-Fite BioPharma (CANF) posted Cash & Current Investments of $2.99 million for Q2 2026, down 53.7% from $6.46 million a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Cash & Current Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Can-Fite BioPharma's Cash & Current Investments came in at $5.53 million, down 29.9% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -7.9% (FY2020 to FY2025).
- In prior years, Can-Fite BioPharma's Cash & Current Investments was $7.88 million in FY2024 (-11.5%), $8.9 million in FY2023 (+102.4%), $4.4 million in FY2022 (-48.3%) and $8.51 million in FY2021 (+1.9%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments since Q1 2023.
- On a year-over-year basis, Cash & Current Investments increased in 1 of the last four quarters, with an average decline of 14.6%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2021, with growth of 206.8%; the weakest was Q2 2022, with a decline of 77.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Can-Fite BioPharma | 1.79 Mn | -17.91 Mn | - | 2.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.99 Mn |
| Dec 31, 2025 | 5.53 Mn |
| Jun 30, 2025 | 6.46 Mn |
| Dec 31, 2024 | 7.88 Mn |
| Jun 30, 2024 | 4.73 Mn |
| Dec 31, 2023 | 8.90 Mn |
| Sep 30, 2023 | 3.39 Mn |
| Jun 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 4.40 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 5.69 Mn |
| Dec 31, 2021 | 8.51 Mn |
| Sep 30, 2021 | 6.16 Mn |
| Jun 30, 2021 | 7.81 Mn |
| Mar 31, 2021 | 3.11 Mn |
| Dec 31, 2020 | 2.77 Mn |
| Sep 30, 2020 | 10.22 Mn |
| Jun 30, 2020 | 9.14 Mn |
API Access
Can-Fite BioPharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();